Delivery Order 75N95021D00024-75N95023F00001
Award Date 8/15/23
Potential Completion Date 12/31/25
Potential Value $246K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Lexington, KY 40509, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute on Drug Abuse (NIDA) awarded a $7,831,331.48 cost-plus-fixed-fee contract to Murty Pharmaceuticals, Inc., a minority-owned small disadvantaged business, for the development and manufacturing of pharmaceutical products to treat substance abuse disorders. The 5-year contract, which runs from September 18, 2016 to September 17, 2021, includes the production of morphine sulfate pellets and methamphetamine hydrochloride in support of NIDA's efforts to develop new medications...
- This federal contract was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Murty Pharmaceuticals, Inc., a minority-owned, small disadvantaged business located in Lexington, Kentucky. The $92,724 firm-fixed-price delivery order is for the development and manufacture of pharmaceutical products for the treatment of substance abuse disorder, with a period of performance from September 13, 2025, to September 12, 2026. Murty Pharmaceuticals has a $7 million single-award...
- Murty Pharmaceuticals, Inc. has been awarded a firm fixed price delivery order against the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse's multiple award contract vehicle for the development and manufacture of pharmaceutical products for the treatment of substance use disorders. The $88,415 contract calls for Murty Pharmaceuticals to conduct drug product stability studies from September 23rd, 2022 through September 22nd, 2023 in support of...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $1,504.65 and an ultimate completion date of November 13, 2023. The contract is for the delivery of Morphine Sulfate, a pharmaceutical product, and is not set aside for any specific type of business. DMS Pharmaceutical Group Inc. holds a...
- This firm-fixed-price purchase order was awarded by the National Institute on Mental Health (NIMH), part of the National Institutes of Health (NIH), to Murty Pharmaceuticals, Inc., a small disadvantaged business, for the manufacture of citalopram and placebo for NIMH research. The $97,279 contract has a performance period ending on July 16, 2017. Murty Pharmaceuticals is a pharmaceutical company focused on research activities and commercial manufacturing in partnership with government and...
- This federal contract award is a delivery order under the Drug Manufacturing and Formulation Program (DMFP) Indefinite Delivery Contract (IDC) awarded to MRI GLOBAL, also known as Midwest Research Institute. The purpose is to de-obligate unexpended and expiring fiscal year 2020 funding in preparation for the closing of the period of availability for these funds. The prime contractor, MRI GLOBAL, is a 501(c)(3) not-for-profit research organization based in Kansas City, Missouri that provides...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to Government Scientific Source Inc. on July 25, 2025, for the supply of Morphine Monohydrate 1.0 mg. This fixed-price contract with economic price adjustment carries a ceiling value of $1,424.05 and is scheduled for ultimate completion by August 15, 2025. The work will be performed in Herndon, Virginia. No set-aside designation was applied to this award. Government Scientific Source Inc., a small business based in...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $2,149.50, is for the delivery of Morphine Sulfate, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, holding a significant single-award...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,052 contract is for the supply of 15 mg immediate-release morphine tablets in bottles of 100 tablets. The contract is a Firm Fixed Price arrangement with a performance period through January 16, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
- This is a delivery order award to Curia Global Inc., doing business as Amri, under the Drug Manufacturing and Formulation Program (DMFP) IDIQ contract with the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services. The $219,167.73 cost-plus-fixed-fee award has a performance period through September 24, 2024 and does not include a set-aside designation. Curia, a leading global contract development and manufacturing organization, will provide...